Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

OBJECTIVES: Liver metastases appear in 20–30% of patients diagnosed with non-small cell lung cancer (NSCLC) and represent a poor prognosis feature of NSCLC and a possibly more treatment-resistant condition. Potential clinical outcome differences in NSCLC patients with liver metastases harboring mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Castañón, Eduardo, Rolfo, Christian, Viñal, David, López, Inés, Fusco, Juan P, Santisteban, Marta, Martin, Patricia, Zubiri, Leire, Echeveste, José I, Gil-Bazo, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528698/
https://www.ncbi.nlm.nih.gov/pubmed/26248464
http://dx.doi.org/10.1186/s12967-015-0622-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528698/
https://www.ncbi.nlm.nih.gov/pubmed/26248464
http://dx.doi.org/10.1186/s12967-015-0622-x

Ejemplares similares